Source link : https://www.newshealth.biz/health-news/mosunetuzumab-in-follicular-lymphoma-durable-responses-and-manageable-safety/
At the recent American Society of Hematology (ASH) annual meeting, updated data on mosunetuzumab (Lunsumio) in relapsed/refractory follicular lymphoma revealed durable responses, particularly in high-risk patients. In this first of four exclusive episodes, MedPage Today brought together three expert leaders in the field, all from the Ohio State University Wexner Medical Center in Columbus: moderator […]
Author : News Health
Publish date : 2024-12-19 17:30:00
Copyright for syndicated content belongs to the linked Source.